Humacyte, Inc.
HUMANASDAQHealthcare● Active
$1.38
+$0.03(+2.22%)
Market Cap$231840000
P/E Ratio—
52W High$2.93
52W Low$0.547
Humacyte, Inc. (HUMA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HUMA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.04M | $0.00M | $0.00M | $1.56M | $1.26M |
| Cost of Revenue | $17.05M | $7.19M | $76.55M | $8.26M | $61.34M |
| Gross Profit | ($15.01M) | ($7.19M) | ($76.55M) | ($6.69M) | ($60.08M) |
| Gross Margin %(computed) | -736.46% | — | — | -427.48% | — |
| Operating Expenses | |||||
| R&D Expenses | $69.30M | $88.60M | $76.55M | $63.26M | $61.34M |
| G&A Expenses | $31.17M | $25.80M | $23.39M | $22.88M | $21.02M |
| Total Operating Expenses | $92.43M | $107.21M | $23.50M | $77.89M | $21.13M |
| Operating Income | ($107.44M) | ($114.40M) | ($100.05M) | ($84.58M) | ($81.21M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $2.59M | $4.10M | $5.47M | $2.63M | $0.02M |
| Interest Expense | $11.25M | $9.28M | $6.60M | $6.20M | $4.35M |
| Income Before Tax | ($40.83M) | ($148.70M) | ($110.78M) | ($11.96M) | ($26.48M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($40.83M) | ($148.70M) | ($110.78M) | ($11.96M) | ($26.48M) |
| Net Margin %(computed) | — | — | — | -764.54% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.26 | $-1.26 | $-1.07 | $-0.12 | $-0.66 |
| Wtd Avg Shares | 158.16M | 118.48M | 103.42M | 103.05M | 39.97M |
| EBITDA | ($100.09M) | ($132.23M) | ($96.46M) | ($76.37M) | ($72.97M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Humacyte, Inc. data
About Humacyte, Inc. (HUMA) Income Statement
Humacyte, Inc. (HUMA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HUMA reported revenue of $0.00B, gross profit of ($0.02B) (gross margin -736.46%), and net income of ($0.04B) — a net profit margin of -2003.58%.
Frequently asked questions
HUMA · 4 questionsHumacyte, Inc. (HUMA) reported revenue of $0.00B for 2025, up —% year-over-year.
HUMA revenueHUMA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08